In comparison to tumors derived from parental LLC cells, those with stable PRMT5 depletion using mouse‐specific shRNAs exhibited significantly reduced tumor growth and weight (Figure 6A,B and Figure S5A, Supporting Information), demonstrating that knockdown of PRMT5 attenuated tumor development. The gene discussed is PRMT5; the disease is neoplasm.